​

Stoke Therapeutics (STOK) Revenue & Revenue Breakdown

OverviewForecastFinancialsChart

Stoke Therapeutics Revenue Highlights

Latest Revenue (Y)

$8.78M

Latest Revenue (Q)

$4.89M

Stoke Therapeutics Revenue by Period

Stoke Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$8.78M-29.22%
2022-12-31$12.40M100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31--

Stoke Therapeutics generated $8.78M in revenue during NA 2023, up -29.22% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Stoke Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30$4.89M1.30%
2024-06-30$4.83M14.59%
2024-03-31$4.22M50.46%
2023-12-31$2.80M-15.30%
2023-09-30$3.31M-233.33%
2023-06-30$-2.48M-148.16%
2023-03-31$5.15M57.60%
2022-12-31$3.27M12.53%
2022-09-30$2.90M-10.09%
2022-06-30$3.23M7.70%
2022-03-31$3.00M100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--

Stoke Therapeutics generated $4.89M in revenue during Q3 2024, up 1.30% compared to the previous quarter, and up -197.26% compared to the same period a year ago.

Stoke Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ARVNArvinas$78.50M$102.40M
ADAPAdaptimmune Therapeutics$60.28M$128.23M
RLAYRelay Therapeutics$25.55M-
STOKStoke Therapeutics$8.78M$4.89M
PLRXPliant Therapeutics$1.58M-
BDTXBlack Diamond Therapeutics--
PASGPassage Bio--

STOK Revenue FAQ

What is Stoke Therapeutics’s yearly revenue?

Stoke Therapeutics's yearly revenue for 2023 was $8.78M, representing a decrease of -29.22% compared to 2022. The company's yearly revenue for 2022 was $12.4M, representing an increase of 100.00% compared to 2021. STOK's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Stoke Therapeutics’s quarterly revenue?

Stoke Therapeutics's quarterly revenue for Q3 2024 was $4.89M, a 1.30% increase from the previous quarter (Q2 2024), and a 47.94% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $4.83M, a 14.59% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). STOK's quarterly revenue for Q1 2024 was $4.22M, a 50.46% increase from the previous quarter (Q4 2023), and a -18.17% decrease year-over-year (Q1 2023).

What is Stoke Therapeutics’s revenue growth rate?

Stoke Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.